Tumor antigens for determining cancer therapy

US11628209B2 · kind B2 · utility

Assignees

• Tron GGMBH · DE
• BIONTECH SE · DE

Inventors

• Ugur Sahin · Mainz, DE
• Claudia Paret · Mainz, DE
• Kirsten Vormbrock · Mainz, DE
• Christian Bender · Mainz, DE
• Petra Simon · Mainz, DE
• Christoph Hartmann · Frankfurt, DE
• Stefanie Hubich · Mainz, DE
• Thomas Bukur · Mainz, DE
• Thorsten Litzenberger · Olsbrücken, DE

Key dates

• Filing date: Dec 21, 2018
• Grant date: Apr 18, 2023
• Expiry date: Feb 2, 2042

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2333/47
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the treatment of cancer, in particular breast cancer, particularly triple-negative breast cancer. More particularly, the invention concerns methods and means for cancer treatment involving a specific set of tumor antigens.